Portage Biotech Inc. (PRTG) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Portage Biotech Inc. (PRTG) Bundle
Engineered for accuracy, our (PRTG) DCF Calculator enables you to evaluate Portage Biotech Inc. valuation using real-world financial data, offering complete flexibility to modify all key parameters for improved projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | .0 | .0 | .0 | -15.8 | -18.2 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | 6.0 | 12.2 | 15.6 | .0 | .1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -6.0 | -12.2 | -15.6 | -15.8 | -18.3 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 3.2 | 2.8 | 23.4 | 10.5 | 5.0 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .6 | .0 | .2 | .7 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .5 | -1.5 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .3 | .1 | .2 | .3 | .5 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | 1.0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 | 12.09 |
| EBITAT | -8.5 | -14.1 | -20.2 | -13.5 | -16.0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -3.3 | 1.4 | -6.2 | -13.9 | -15.1 | -.4 | .0 | .0 | .0 | .0 |
| WACC, % | 473.81 | 473.81 | 473.81 | 473.8 | 473.8 | 473.81 | 473.81 | 473.81 | 473.81 | 473.81 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -5 | |||||||||
| Equity Value | 5 | |||||||||
| Diluted Shares Outstanding, MM | 20 | |||||||||
| Equity Value Per Share | 0.24 |
What You Will Get
- Comprehensive PRTG Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Testing: Evaluate various scenarios to analyze Portage Biotech's potential future performance.
- User-Friendly Interface: Designed for industry professionals but easy for newcomers to navigate.
Key Features
- 🔍 Real-Life PRTG Financials: Pre-filled historical and projected data for Portage Biotech Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Portage’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Portage’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file for Portage Biotech Inc. (PRTG).
- Step 2: Review Portage Biotech’s pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment decisions.
Why Choose the Portage Biotech Inc. (PRTG) Calculator?
- User-Friendly Interface: Perfectly suited for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters easily to suit your specific analysis needs.
- Real-Time Valuation: Observe immediate updates to Portage Biotech's valuation with each input change.
- Pre-Loaded Data: Comes with Portage Biotech's actual financial metrics for swift evaluations.
- Relied Upon by Experts: A go-to tool for investors and analysts seeking to make well-informed choices.
Who Should Use This Product?
- Biotech Students: Explore drug development processes and apply methodologies using real-world data.
- Researchers: Integrate advanced models into your studies or academic publications.
- Investors: Validate your investment strategies and assess valuation metrics for Portage Biotech Inc. (PRTG).
- Market Analysts: Enhance your analysis with a ready-to-use, customizable financial model.
- Entrepreneurs: Understand how biotechnology firms like Portage Biotech Inc. (PRTG) are evaluated in the market.
What the Template Contains
- Preloaded PRTG Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.